171 related articles for article (PubMed ID: 3474661)
1. Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation.
Weiss MJ; Wong JR; Ha CS; Bleday R; Salem RR; Steele GD; Chen LB
Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5444-8. PubMed ID: 3474661
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of rat colon tumor isograft growth with dequalinium chloride.
Bleday R; Weiss MJ; Salem RR; Wilson RE; Chen LB; Steele G
Arch Surg; 1986 Nov; 121(11):1272-5. PubMed ID: 3778199
[TBL] [Abstract][Full Text] [Related]
3. AA1, a newly synthesized monovalent lipophilic cation, expresses potent in vivo antitumor activity.
Sun X; Wong JR; Song K; Hu J; Garlid KD; Chen LB
Cancer Res; 1994 Mar; 54(6):1465-71. PubMed ID: 8137249
[TBL] [Abstract][Full Text] [Related]
4. Anticarcinoma activity of a novel drug, 3-ethyl-3'-methyl-thiatelluracarbocyanine iodide (Te), a tellurium-containing cyanine targeted at mitochondria.
Sun X; Wong JR; Song K; Chen LB
Clin Cancer Res; 1996 Aug; 2(8):1335-40. PubMed ID: 9816305
[TBL] [Abstract][Full Text] [Related]
5. Study of the selective cytotoxic properties of cationic, lipophilic mitochondrial-specific compounds in gynecologic malignancies.
Christman JE; Miller DS; Coward P; Smith LH; Teng NN
Gynecol Oncol; 1990 Oct; 39(1):72-9. PubMed ID: 2227576
[TBL] [Abstract][Full Text] [Related]
6. Failure to enhance the in vivo killing of human ovarian carcinoma by sequential treatment with dequalinium chloride and tumor necrosis factor.
Manetta A; Emma D; Gamboa G; Liao S; Berman M; DiSaia P
Gynecol Oncol; 1993 Jul; 50(1):38-44. PubMed ID: 8349163
[TBL] [Abstract][Full Text] [Related]
7. Selective antimitochondrial agents inhibit calmodulin.
Bodden WL; Palayoor ST; Hait WN
Biochem Biophys Res Commun; 1986 Mar; 135(2):574-82. PubMed ID: 3008727
[TBL] [Abstract][Full Text] [Related]
8. [Maltyl gargling solution. Report on an experiment using a new, ready-to-use antiseptic (dequalinium chloride) for the mouth and throat].
Engel P
ZFA (Stuttgart); 1982 Jun; 58(17):979-82. PubMed ID: 7113393
[No Abstract] [Full Text] [Related]
9. Anticarcinoma activity in vivo of rhodamine 123, a mitochondrial-specific dye.
Bernal SD; Lampidis TJ; McIsaac RM; Chen LB
Science; 1983 Oct; 222(4620):169-72. PubMed ID: 6623064
[TBL] [Abstract][Full Text] [Related]
10. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of tonsillitis with dequalinium chloride].
Krämer W
Fortschr Med; 1977 Apr; 95(16):1108-10. PubMed ID: 856702
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of rodent protein kinase C by the anticarcinoma agent dequalinium.
Rotenberg SA; Smiley S; Ueffing M; Krauss RS; Chen LB; Weinstein IB
Cancer Res; 1990 Feb; 50(3):677-85. PubMed ID: 2297708
[TBL] [Abstract][Full Text] [Related]
13. The use of dequalinium acetate as a disinfectant and chemotherapeutic agent in endodontics.
Kaufman AY
Oral Surg Oral Med Oral Pathol; 1981 Apr; 51(4):434-41. PubMed ID: 6940082
[TBL] [Abstract][Full Text] [Related]
14. MKT-077, a novel rhodacyanine dye in clinical trials, exhibits anticarcinoma activity in preclinical studies based on selective mitochondrial accumulation.
Koya K; Li Y; Wang H; Ukai T; Tatsuta N; Kawakami M; Shishido ; Chen LB
Cancer Res; 1996 Feb; 56(3):538-43. PubMed ID: 8564968
[TBL] [Abstract][Full Text] [Related]
15. Rhodamine-123 selectively reduces clonal growth of carcinoma cells in vitro.
Bernal SD; Lampidis TJ; Summerhayes IC; Chen LB
Science; 1982 Dec; 218(4577):1117-9. PubMed ID: 7146897
[TBL] [Abstract][Full Text] [Related]
16. [Doubleblind test of dequalinium chloride in 60 children with oral moniliasis].
Krämer W
Fortschr Med; 1977 May; 95(18):1246. PubMed ID: 324879
[No Abstract] [Full Text] [Related]
17. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines.
Hait WN; Pierson NR
Cancer Res; 1990 Feb; 50(4):1165-9. PubMed ID: 2297765
[TBL] [Abstract][Full Text] [Related]
18. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells.
Modica-Napolitano JS; Aprille JR
Adv Drug Deliv Rev; 2001 Jul; 49(1-2):63-70. PubMed ID: 11377803
[TBL] [Abstract][Full Text] [Related]
19. [Marine-dental experiences with the symptomatic local drug Corti-Dynexan].
Löpelmann J
ZWR; 1974 May; 83(10):531-5. PubMed ID: 4534167
[No Abstract] [Full Text] [Related]
20. Mitochondrial targeting for photochemotherapy. Can selective tumor cell killing be predicted based on n-octanol/water distribution coefficients?
Belostotsky I; da Silva SM; Paez MG; Indig GL
Biotech Histochem; 2011 Oct; 86(5):302-14. PubMed ID: 20465515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
